Vanguard Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $335K | Hold |
|
|||||
|
2024
Q4 | $574K | Buy |
|
|||||
|
2024
Q3 | $809K | Buy |
|
|||||
|
2024
Q2 | $369K | Hold |
|
|||||
|
2024
Q1 | $312K | Buy |
|
|||||
|
2023
Q4 | $1.2M | Buy |
|
|||||
|
2023
Q3 | $1.74M | Buy |
|
|||||
|
2023
Q2 | $2.35M | Buy |
|
|||||
|
2023
Q1 | $2.01M | Buy |
|
|||||
|
2022
Q4 | $2.02M | Buy |
|
|||||
|
2022
Q3 | $4.29M | Buy |
|
|||||
|
2022
Q2 | $2.29M | Buy |
|
|||||
|
2022
Q1 | $1.9M | Sell |
|
|||||
|
2021
Q4 | $9.39M | Buy |
|
|||||
|
2021
Q3 | $10.1M | Buy |
|
|||||
|
2021
Q2 | $13.7M | Buy |
|
|||||
|
2021
Q1 | $13.4M | Sell |
|
|||||
|
2020
Q4 | $12.5M | Buy |
|
|||||
|
2020
Q3 | $17.5M | Buy |
|
|||||
|
2020
Q2 | $22.8M | Buy |
|
|||||
|
2020
Q1 | $11.9M | Buy |
|
|||||
|
2019
Q4 | $24M | Buy |
|
|||||
|
2019
Q3 | $26.2M | Buy |
|
|||||
|
2019
Q2 | $31.9M | Buy |
|
|||||
|
2019
Q1 | $29.2M | Buy |
|
|||||
|
2018
Q4 | $15.7M | Buy |
|
|||||
|
2018
Q3 | $29.6M | Buy |
|
|||||
|
2018
Q2 | $28.6M | Sell |
|
|||||
|
2018
Q1 | $31.1M | Buy |
|
|||||
|
2017
Q4 | $34.9M | Buy |
|
|||||
|
2017
Q3 | $28.9M | Buy |
|
|||||
|
2017
Q2 | $33.8M | Buy |
|
|||||
|
2017
Q1 | $28.1M | Buy |
|
|||||
|
2016
Q4 | $21.8M | Buy |
|
|||||
|
2016
Q3 | $28.6M | Sell |
|
|||||
|
2016
Q2 | $15.7M | Buy |
|
|||||
|
2016
Q1 | $15.6M | Buy |
|
|||||
|
2015
Q4 | $21.6M | Buy |
|
|||||
|
2015
Q3 | $14M | Buy |
|
|||||
|
2015
Q2 | $21.7M | Buy |
|
|||||
|
2015
Q1 | $18.6M | Buy |
|
|||||
|
2014
Q4 | $15.3M | Buy |
|
|||||
|
2014
Q3 | $16.3M | Buy |
|
|||||
|
2014
Q2 | $15.5M | Buy |
|
|||||
|
2014
Q1 | $12.5M | Buy |
|
|||||
|
2013
Q4 | $5.68M | Buy |
|
|||||
|
2013
Q3 | $5.25M | Buy |
|
|||||
|
2013
Q2 | $2.42M | Buy |
|